Barlow’s Research Roundup: Six changes to RBC’s top 30 global stock ideas

RBC Capital Markets co-heads of global research Graeme Pearson and Mark Odendahl updated their “Top 30” global stock list, adding Apotex Health, Canadian National Railway, Lonza and deleting Alcon, Boston Scientific and DuPont. The list returned 11.1% in USD in Q2/26. Separate notes cover Scotiabank’s view on KMP REIT rents and BofA’s metals outlook, cutting 32 price objectives and highlighting CCJ, FCX and PAAS.

Original reporting
Published Jul 9, 2026, 2:30 PM UTC
Analysis
alphai AI DeskAI-generated
Added to alphai Jul 9, 2026, 2:37 PM UTC. Informational, not investment advice.
How this was made
alphai summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
Barlow’s Research Roundup: Six changes to RBC’s top 30 global stock ideas — source image
Decision brief

The 30-second read

$CNIBullishLow
01

Why it matters

Trading relevance is mainly in relative positioning signals: KMP is explicitly supported by June rent data and a maintained buy stance, while metals names are framed through revised commodity forecasts and top-pick reiterations.

02

Market read

This is primarily a research-driven positioning update, with the clearest actionable datapoint being KMP’s rent growth and the explicit maintained trade stance into Q2 results.

03

What to watch

Actual price impact depends on whether the market already priced in RBC/BofA views; without new company-specific fundamentals, follow-through may be limited.

Relevance 4/10Novelty 4/10Timing: today’s research roundup, ahead of upcoming Q2 company updates

Background

The article is a daily research roundup summarizing RBC’s quarterly top-30 stock list changes, a Scotiabank rent-data read-through for Canadian REITs, and a BofA commodities forecast update with metals top picks.

Company-level read

Ticker impact

$CNIBullishMedium confidence
Context

Canadian National Railway was added to RBC’s top 30 global stock ideas, implying a renewed bullish stance from the research team.

Expected impact

Low-to-moderate positive bias, mostly for traders tracking research momentum.

Evidence & confidence

No company-specific new facts (results, contracts, guidance) are provided, only the index-style inclusion change.

$ALCBearishMedium confidence
Context

Alcon was deleted from RBC’s top 30 global stock ideas, a negative research signal that could pressure sentiment.

Expected impact

Mild negative bias possible; magnitude likely limited absent other news.

Evidence & confidence

The text only states the deletion, with no new Alcon datapoint explaining the change.

$BSXBearishMedium confidence
Context

Boston Scientific was removed from RBC’s top 30 global stock ideas, suggesting reduced conviction versus prior positioning.

Expected impact

Slight downside bias possible; not expected to be large without additional catalysts.

Evidence & confidence

No new BSX fundamentals or valuation changes are included beyond the list update.

$DDBullishMedium confidence
Context

DuPont de Nemours was added to RBC’s top 30 global stock ideas, indicating a renewed bullish research view.

Expected impact

Modest positive bias; follow-through depends on other market catalysts.

Evidence & confidence

The article discloses only the inclusion, not any new DD-specific numbers.

$CARNeutralHigh confidence
Context

RBC’s real estate analyst notes CAR is flat on June asking rent data, contributing to a more patient stance versus KMP.

Expected impact

Neutral-to-slightly negative bias relative to KMP; not a standalone catalyst.

Evidence & confidence

The text provides CAR’s rent change (flat) and ties it to the analyst’s comparative trade posture.

$CCJBullishMedium confidence
Context

BofA highlights uranium as highest-conviction upside and lists CCJ as a top pick amid reduced precious and base metal forecasts.

Expected impact

Potential positive support for CCJ relative to other metals names despite broader commodity caution.

Evidence & confidence

The article provides a top-pick and upside potential for uranium, but it is still an analyst-forecast update rather than a new CCJ-specific event.

$FCXBullishMedium confidence
Context

BofA reiterates Freeport-McMoRan (FCX) as its top base metals pick, citing 35% upside potential to its price objective.

Expected impact

Moderate positive bias; likely strongest for traders aligned to copper and turnaround leverage.

Evidence & confidence

The article includes a specific upside figure and rationale, but no new FCX operational disclosure.

$PAASBullishMedium confidence
Context

BofA names Pan American Silver (PAAS) as a top pick while cutting 32 price objectives across precious metals.

Expected impact

Slight-to-moderate positive relative bias versus other precious metals names.

Evidence & confidence

The article provides the top-pick list but does not give PAAS-specific new fundamentals beyond the sector framework.

Market effects

Signals relative positioning across Canadian REITs and metals equities, with uranium/copper framed as higher-conviction versus precious/base metals broadly.

Canada: rent-data read-across supports KMP and keeps BEI/CAR more cautious.

Global commodities-linked equities may see relative rotation toward uranium and copper exposure despite broader forecast cuts.

Counterpoint

List additions/deletions and top-pick calls may be largely sentiment-driven and can underperform if commodity price action contradicts the forecast framework.

Key entities

  • RBC Capital Markets

    Updated its quarterly top-30 global stock ideas with specific additions and deletions.

  • Scotiabank real estate analyst Mario Saric

    Interpreted Rentals.ca June rent data and reiterated a buy stance for KMP while staying more patient on BEI and CAR.

  • BofA Securities commodities analyst Lawson Winder

    Cut near-term commodity price forecasts and reiterated uranium/copper upside with CCJ and FCX as top picks.

Related articles

$CCJMed

Cameco (CCJ) Q2 2026 Earnings Call Transcript

Cameco (CCJ) held its Q2 2026 earnings call. Management maintained a 2026 U3O8 production outlook of 19.5 million to 21.5 million pounds despite temporary Northern Saskatchewan disruptions. It cited long-term uranium contract deliveries above 28 million pounds annually, Westinghouse AP1000 support of $17.5 billion for long-lead items, and a confidential SEC Form S-1 for a potential Westinghouse IPO.

$DDMedAI 8/10

New Jersey Judge Approves $2.5 Billion PFAS Settlements With DuPont and 3M

A New Jersey federal judge approved PFAS settlements totaling over $2.5 billion with DuPont, Chemours, Corteva and 3M, Reuters reported. The deals require cleanup of four former sites and compensation for natural-resource damages, including a $1.2 billion restoration fund. DuPont, Chemours and Corteva pay $875 million over 25 years; 3M pays $400-$450 million, plus a $475 million reserve.

$DDMedAI 8/10

New Jersey’s $2.5 billion ’forever chemicals’ settlements with DuPont, 3M, others win court approval

A federal judge approved New Jersey’s PFAS settlement totaling over $2.5 billion with DuPont, Chemours, Corteva and 3M, according to Reuters. DuPont, Chemours and Corteva will pay $875 million over 25 years, including site cleanup and a $1.2 billion remediation fund. 3M will pay $400 million to $450 million. The ruling overruled municipal objections.

$FCXMed

FREEPORT-MCMORAN INC 2Q 2026: Revenue $7.03B, EPS $0.68— 10-Q Summary

Freeport-McMoRan reported 2Q 2026 revenue of $7.03B and diluted EPS of $0.68, citing higher realized copper and gold prices and operational gains in the U.S. Net income fell to $1.39B from $1.55B year over year. The company said Grasberg ramp-up continues and a smelter restart is planned for H2 2026, with leach tech targeting incremental copper by end-2026.

$DDMedAI 8/10

DuPont de Nemours, Inc. Q2 2026 Earnings Call Summary

DuPont de Nemours reported Q2 2026 results driven by broad-based organic growth in healthcare, aerospace and industrial water, plus productivity gains. Management raised full-year organic growth guidance to slightly above 4% and expects H2 growth near 6%. Free cash flow conversion should exceed 90%. A $250m share repurchase is planned for Q3 2026.